Geneoscopy
Latest round
- Series C
Last raised
- Jan 2025
Total raised
- $112M
Investors
- 12
About Geneoscopy
Geneoscopy, Inc.Founded in 2015 and headquartered in St. Louis, US, Geneoscopy, Inc. develops innovative diagnostic solutions for gastrointestinal health.63 mn.Geneoscopy specializes in innovative, noninvasive diagnostic tests primarily focused on gastrointestinal health. Their flagship product leverages stool-derived eukaryotic RNA (seRNA) technology to develop molecular-based screening tests for colorectal cancer, aimed at improving the prevention, early detection, and monitoring of this prevalent disease. By utilizing advanced molecular technologies, Geneoscopy addresses significant barriers associated with traditional screening methods, such as colonoscopies, which often deter over 40% of eligible patients from getting screened. The company also focuses on diagnostics for inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease, enhancing the overall management of gastrointestinal disorders.Geneoscopy's revenue is generated through the direct sale of its advanced diagnostic testing services, predominantly to healthcare providers and institutions focusing on gastrointestinal health. These services are structured as a direct-to-consumer model, allowing patients to access testing through their healthcare providers without the need for invasive procedures. The company has established partnerships with various healthcare entities, which facilitates the utilization of their molecular-based tests in clinical settings. Geneoscopy’s pricing strategy is centered around their proprietary seRNA technology, with costs related to their colorectal cancer screening tests structured to be competitive within the diagnostics market. The company is also strategizing on entering new markets, with specific targets set for expansion in North America and Europe, aiming for a rollout by the end of 2025. These initiatives are geared towards enhancing its product offerings and increasing accessibility to their innovative diagnostic solutions.
Who invested in Geneoscopy
12 investors across 4 rounds
See all investors in Geneoscopy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Geneoscopy
Who invested in Geneoscopy?
Geneoscopy has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Geneoscopy raised?
Geneoscopy has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Geneoscopy last raise money?
Geneoscopy's most recent round on record is a Series C, in Jan 2025.
What does Geneoscopy do?
Geneoscopy is a biotechnology company.
Where is Geneoscopy headquartered?
Geneoscopy is headquartered in St. Louis, US.
Which VCs invest in companies like Geneoscopy?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Geneoscopy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Geneoscopy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.